Our Pricing

Semaglutide Injections Online Prescription UK

Published on: June 03, 2026

Accessing semaglutide injections online prescription UK has never been more straightforward for eligible patients. At Cured Pharmacy, our UK-registered clinical team provides comprehensive assessments in under 3 minutes, prescribing genuine Wegovy (semaglutide) injections from £79.00 with transparent pricing shown before your consultation. All prescriptions are issued by qualified UK prescribers following MHRA-approved clinical protocols.

How Semaglutide Injections Work for Weight Loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces after eating. It works by slowing gastric emptying, reducing appetite signals in the brain, and improving insulin sensitivity—three mechanisms that together support clinically significant weight reduction when combined with lifestyle modifications [1].

The STEP clinical trial programme demonstrated that adults using semaglutide 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results led to MHRA licensing of Wegovy (semaglutide) specifically for chronic weight management in the UK in 2022.

Unlike older weight loss medications that work through single pathways, semaglutide's multi-mechanism approach addresses both the physiological and neurological aspects of appetite regulation. Patients typically notice reduced hunger and increased satiety within the first few weeks of treatment, though optimal results require adherence to the full dose escalation schedule over several months [2].

Who Can Access Semaglutide Injections Online in the UK

Semaglutide is a prescription-only medicine in the UK, meaning you must be clinically assessed by a UK-registered prescriber before treatment can begin. NICE guidelines recommend GLP-1 receptor agonists for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3].

During your online consultation at Cured Pharmacy, our prescribers will review your medical history, current medications, and weight management goals to determine if semaglutide is appropriate and safe for you. Certain conditions may preclude treatment, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy.

The consultation process is designed to replicate the thoroughness of an in-person GP appointment whilst offering the convenience of digital access. You'll receive a decision within hours, and if approved, your prescription is sent directly to our UK-registered pharmacy for dispensing and discreet delivery to your chosen address.

Medical Conditions That May Affect Eligibility

Your prescriber will carefully assess contraindications including diabetic retinopathy, pancreatitis history, renal impairment, and concurrent use of other weight loss medications. Full disclosure of your medical history ensures safe prescribing and minimises potential adverse effects. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical protocols to maintain the highest standards of patient safety.

Semaglutide Dosing Schedule and What to Expect

Wegovy follows a structured dose escalation protocol designed to minimise gastrointestinal side effects whilst building therapeutic efficacy. Treatment begins at 0.25mg weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg, reaching the maintenance dose of 2.4mg by week 17 [2].

This gradual titration allows your body to adapt to the medication's effects on gastric emptying and appetite regulation. Most patients experience the greatest weight reduction during the maintenance phase, though some notice appetite changes within the first fortnight. Clinical trials show that patients who complete the full escalation schedule achieve significantly better outcomes than those who rush the process.

Each Wegovy pen is pre-filled and administered via subcutaneous injection once weekly, typically in the abdomen, thigh, or upper arm. The injection process takes seconds, and most patients report minimal discomfort. Consistency in timing—choosing the same day each week—helps maintain stable therapeutic levels and supports adherence to your weight management programme.

Managing Common Side Effects

Nausea, diarrhoea, and constipation are the most frequently reported side effects, typically occurring during dose escalations and resolving within days to weeks [1]. Eating smaller, more frequent meals and avoiding high-fat foods can help minimise gastrointestinal symptoms. If side effects persist or become severe, your prescriber may recommend remaining at your current dose for an additional month before escalating further.

Comparing Semaglutide to Other Weight Loss Treatments

The UK market for prescription weight loss medications has expanded considerably, with several GLP-1 receptor agonists now licensed for chronic weight management. Semaglutide (Wegovy) was the first weekly injectable to demonstrate weight reductions exceeding 15% in clinical trials, setting a new benchmark for pharmacological obesity treatment [1].

Liraglutide (Saxenda), an earlier GLP-1 medication, requires daily injections and typically produces more modest weight loss averaging 8% over 56 weeks in the SCALE trial programme [4]. Whilst effective, the daily injection requirement and lower efficacy have made weekly semaglutide a preferred option for many patients and prescribers.

Tirzepatide (Mounjaro), the newest entrant, is a dual GIP/GLP-1 receptor agonist showing even greater weight reductions in head-to-head trials—up to 22.5% in SURPASS-3 [5]. However, tirzepatide currently costs considerably more than semaglutide in the UK private market, making Wegovy a cost-effective choice for patients seeking proven GLP-1 therapy without premium pricing.

Why Choose Cured Pharmacy for Your Semaglutide Prescription

As a GPhC-registered online pharmacy (9012511), we operate under the same rigorous standards as traditional high-street pharmacies whilst offering the convenience of digital consultations and home delivery. Our pricing model is transparent—you see the exact cost before beginning your consultation, with no hidden fees or subscription traps.

At £79.00 for Wegovy, we guarantee the lowest prices in the UK for genuine, MHRA-licensed semaglutide injections. Every pen is sourced directly from licensed UK wholesalers and stored in our temperature-controlled pharmacy to maintain efficacy. We never dispense parallel imports or grey-market products.

Your clinical assessment is conducted by UK-registered prescribers who specialise in weight management and metabolic health. They have access to your full consultation responses and can provide ongoing support throughout your treatment journey. Follow-up consultations are included at no additional cost, ensuring continuity of care as you progress through dose escalations.

Discreet Packaging and Reliable Delivery

All orders are dispatched in plain, unmarked packaging with no external indication of contents. We use temperature-controlled courier services to maintain the cold chain required for injectable medications, with tracking provided for every delivery. Most patients receive their prescription within 2-3 working days of approval.

Starting Your Semaglutide Treatment Journey Today

Beginning treatment requires just three steps: complete our online medical questionnaire (typically under 3 minutes), receive your prescriber's decision within hours, and have your medication delivered discreetly to your door. The questionnaire covers your weight history, previous weight loss attempts, current medications, and relevant medical conditions to ensure safe prescribing.

Once approved, you'll receive detailed injection instructions, dose escalation guidance, and lifestyle modification recommendations to optimise your results. Our clinical team remains available throughout your treatment for questions about side effects, dosing, or general weight management support.

Semaglutide is most effective when combined with a reduced-calorie diet and increased physical activity. Clinical trials required participants to receive nutritional counselling and lifestyle support alongside medication [1]. Whilst we provide educational resources, we strongly encourage working with a registered dietitian or nutritionist to develop sustainable eating patterns that support long-term weight maintenance beyond medication use.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for Managing Overweight and Obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and are not guaranteed.